Riskpilot← Back to searchSign inGet full accessN-vet AB
ABActiveOrg 5566059985Dag Hammarskjölds Väg 36 BWholesale of pharmaceutical and medical goods · NACE 4646Est. 20014 employees
Revenue 2025
SEK 23,4M
+8% vs 2024
EBITDA margin
11.8%
+259% vs 2024
Equity ratio
61.6%
Financial strength
Net profit 2025
SEK 2,3M
+213% vs 2024
| Revenue | SEK 23,4M | +8% |
| EBITDA | SEK 2,7M | +259% |
| Net profit | SEK 2,3M | +213% |
| Total assets | SEK 14,2M | +23% |
| Equity | SEK 8,8M | +36% |
| Employees | 4 | — |
Legal name
N-vet AB
Org number
5566059985
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25 januari 2001
Share capital
SEK 600 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva försäljning av läkemedel, forskning och utveckling av veterinärläkemedel samt konsult- och kursverksamhet i anslutning därtill ävensom idka därmed förenlig verksamhet.
Address
Dag Hammarskjölds Väg 36 B
Phone
+4618572430
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 21 734 | 22 441 | 20 412 | 21 647 | 23 357 |
| Staff expenses | — | — | −3 734 | — | −3 676 |
| EBITDA | 920 | 2 040 | 2 467 | −1 725 | 2 747 |
| Depreciation & amort. | −7 | −10 | −12 | −7 | −5 |
| EBIT | 913 | 2 030 | 2 455 | −1 732 | 2 742 |
| Net financials | −4 | −7 | 56 | 42 | 8 |
| Profit before tax | 910 | 2 023 | 2 511 | −1 691 | 2 750 |
| Tax | −204 | −444 | −551 | −380 | −413 |
| Net profit | 706 | 1 579 | 1 960 | −2 071 | 2 337 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 18 487 | 15 434 | 15 982 | 11 515 | 14 218 |
| Equity | 13 947 | 12 026 | 10 987 | 6 415 | 8 752 |
| Long-term debt | 0 | 0 | — | 0 | — |
| Short-term debt | 4 540 | 3 407 | 4 995 | 5 100 | 5 465 |
| Total debt | 4 540 | 3 407 | 4 995 | 5 100 | 5 465 |
EBITDA margin
11.8%
This company
15.8%
Market median
-25% vs market
20212025
Equity ratio
61.6%
This company
38.2%
Market median
+61% vs market
20212025
Return on equity
26.7%
This company
18.4%
Market median
+45% vs market
20212025
Net profit margin
10.0%
This company
8.1%
Market median
+23% vs market
20212025
Asset turnover
1.64×
This company
1.12×
Market median
+46% vs market
20212025
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KO Chief Auditor | Chief Auditor | 2022 |
KE Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
TP Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2026 | |
| Former (5) | ||
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2026 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2024 – 2026 | |
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ALIVIRA HEALTH LTD
N-vet AB (this company)Board members of N-vet AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kenth Olof Nordin | Chief Auditor | 0 companies |
| Tushar Pravinchandra Mistry | Chief Auditor | 0 companies |
| Katarina Elisabeth Ågren | Chief Executive Officer | 0 companies |
| Venkat Raghavendra Rao Patri | Board of Directors | 0 companies |
| Claes Göran Ingemar Sjösten | Board of Directors | 0 companies |
| Ramon Vila | Chairman | 0 companies |
| Alexis Henri Gaetan Goux | Board of Directors | 0 companies |
| Asmish Dilip Kakabalia | Board of Directors | 0 companies |
| Ramakant Singani | Board of Directors | 0 companies |
| Saurav Bhala | Board of Directors | 0 companies |
| Manish Gupta | Board of Directors | 0 companies |